ConductScience.org, home

Paper6132360

Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxygenase deficiency with acute intermittent ataxia and without visceral and bone involvement.

Giardini O and 3 others. Pediatr Res, 1983. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxygenase deficiency with acute intermittent ataxia and without visceral and bone involvement. Papers, record 6132360. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6132360

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxygenase deficiency with acute intermittent ataxia and without visceral and bone involvement.
PubMed
Journal
Pediatr Res
PubMed
Year
1983
PubMed
Publication types
Case Reports, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.48
iCite
Revised in PubMed
2019-09-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Giardini OO
2Cantani AA
3Kennaway NGN G
4D'Eufemia PP

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
4-Hydroxyphenylpyruvate DioxygenaseMajor topic
AtaxiaMajor topic
LiverMajor topic
OxygenasesMajor topic
TyrosineMajor topic
Chronic Disease
Cytosol
Female
Glutamate Dehydrogenase
Humans
Infant
L-Lactate Dehydrogenase
Mitochondria, Liver
Phosphogluconate Dehydrogenase
Tyrosine Transaminase

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
42140431Disease associated missense substitutions disrupt structural stability and catalytic function of 4-hydroxyphenylpyruvate dioxygenase.J Biol Chem2026https://conductscience.org/library/papers/42140431PubMed
36048613The Human Glyoxalase Gene Family in Health and Disease.Chem Res Toxicol2022https://conductscience.org/library/papers/36048613PubMed
35707594Novel Cranial Imaging Findings and a Splice-Site Variant in a Patient with Tyrosinemia Type III, and a Summary of Published Cases.Mol Syndromol2022https://conductscience.org/library/papers/35707594PubMed
32520295TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW.Rev Paul Pediatr2020https://conductscience.org/library/papers/32520295PubMed
29456978A Case of Tyrosinemia Type III with Status Epilepticus and Mental Retardation.Adv Biomed Res2018https://conductscience.org/library/papers/29456978PubMed
22687740Hepatorenal tyrosinemia.Proc Jpn Acad Ser B Phys Biol Sci2012https://conductscience.org/library/papers/22687740PubMed
16706549Nitisinone in the treatment of hereditary tyrosinaemia type 1.Drugs2006https://conductscience.org/library/papers/16706549PubMed
11916315Outcome of tyrosinaemia type III.J Inherit Metab Dis2001https://conductscience.org/library/papers/11916315PubMed
9728332Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.J Inherit Metab Dis1998https://conductscience.org/library/papers/9728332PubMed
9728330From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug.J Inherit Metab Dis1998https://conductscience.org/library/papers/9728330PubMed
8598649Benign tyrosinaemia: an 18-year follow-up.J Inherit Metab Dis1995https://conductscience.org/library/papers/8598649PubMed
7474904Immunological abnormalities in a patient with tyrosinaemia type III.J Inherit Metab Dis1995https://conductscience.org/library/papers/7474904PubMed
2246865Putative genetic deficiency of 4-hydroxyphenylpyruvic acid dioxygenase in mice: a murine model for hereditary tyrosinaemia type III.J Inherit Metab Dis1990https://conductscience.org/library/papers/2246865PubMed
2014797A murine model for type III tyrosinemia: lack of immunologically detectable 4-hydroxyphenylpyruvic acid dioxygenase enzyme protein in a novel mouse strain with hypertyrosinemia.Am J Hum Genet1991https://conductscience.org/library/papers/2014797PubMed
1293381Autoimmune thyroiditis in a case of tyrosinaemia type III.J Inherit Metab Dis1992https://conductscience.org/library/papers/1293381PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HPD3242PubTator's text mininghttps://conductscience.org/library/genes/3242NCBI Gene
PGD5226PubTator's text mininghttps://conductscience.org/library/genes/5226NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6132360

GET https://conductscience.org/api/papers/v1/6132360/authors